TI
LXRX icon

Trexquant Investment’s Lexicon Pharmaceuticals LXRX Stock Holding History

Trexquant Investment’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-14,563
Closed -$92K – 1002
2019
Q2 		$92K Buy
+14,563
New +$87.2K 0.01% 748
2019
Q1 		– Sell
-10,117
Closed -$67K – 1164
2018
Q4 		$67K Sell
10,117
-7,364
-42% -$59.7K ﹤0.01% 999
2018
Q3 		$187K Sell
17,481
-2,195
-11% -$25.2K 0.01% 838
2018
Q2 		$236K Sell
19,676
-1,007
-5% -$10.3K 0.02% 744
2018
Q1 		$177K Buy
+20,683
New +$191K 0.01% 965
2017
Q2 		– Sell
-22,535
Closed -$323K – 1003
2017
Q1 		$323K Buy
+22,535
New +$334K 0.04% 725

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return